Literature DB >> 11319922

Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.

Y Saeki1, C Fraefel, T Ichikawa, X O Breakefield, E A Chiocca.   

Abstract

Herpes simplex virus type 1 (HSV-1) amplicons are prokaryotic plasmids containing one or more transcriptional units and two cis-acting HSV-1 sequences: a viral origin of DNA replication and a viral DNA cleavage/packaging signal. In the presence of HSV-1 "helper" functions, amplicons are replicated and packaged into HSV-1 virions. Despite recent improvements in packaging methods, stocks of amplicon vectors are still contaminated with replication-competent helper virus at a frequency of 10(-4)-10(-6). To overcome this problem, we report that: (i) genetic modifications of HSV-1 genomes can be routinely achieved in Escherichia coli, either by homologous or site-specific recombination, (ii) a novel HSV-1 bacterial artificial chromosome (fHSVDeltapacDelta27 0+), which has a deletion in the essential gene encoding ICP27 and an addition of ICP0 "stuffer" sequences to increase its size to 178 kb, supports the replication and packaging of cotransfected amplicon DNA without generating replication-competent helper virus (<1 helper virus per 10(8) TU amplicon vectors), and (iii) the resulting amplicon stocks have titers of up to 3-10 x 10(8) TU/ml after concentration. Elimination of replication-competent helper virus from HSV-1 amplicon vector stocks further improves safety in gene transfer applications.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11319922     DOI: 10.1006/mthe.2001.0294

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  50 in total

1.  MRI of transgene expression: correlation to therapeutic gene expression.

Authors:  Tomotsugu Ichikawa; Dagmar Högemann; Yoshinaga Saeki; Edyta Tyminski; Kinya Terada; Ralph Weissleder; E Antonio Chiocca; James P Basilion
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

Review 2.  Herpes simplex virus-based vectors.

Authors:  Robin Lachmann
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

3.  Use of Adeno-Associated and Herpes Simplex Viral Vectors for In Vivo Neuronal Expression in Mice.

Authors:  Rachel D Penrod; Audrey M Wells; William A Carlezon; Christopher W Cowan
Journal:  Curr Protoc Neurosci       Date:  2015-10-01

4.  Volumetric tomography of fluorescent proteins through small animals in vivo.

Authors:  Giannis Zacharakis; Hirokazu Kambara; Helen Shih; Jorge Ripoll; Jan Grimm; Yoshinaga Saeki; Ralph Weissleder; Vasilis Ntziachristos
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

Review 5.  Immune responses to herpesviral vectors.

Authors:  Deborah A Ryan; Howard J Federoff
Journal:  Hum Gene Ther       Date:  2009-05       Impact factor: 5.695

Review 6.  Viral vectors: from virology to transgene expression.

Authors:  D Bouard; D Alazard-Dany; F-L Cosset
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

7.  Assessment of a cellular vaccination approach consisting of crawling dendritic cells (CDCs) transduced with HSV-1-Deltapac vectors.

Authors:  Rafael Nuñez; Cornel Fraefel; Mark Suter; Anne Nuñez-Liman; Hsiou-Chi Liou; Mathias Ackerman
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

8.  Epstein-Barr virus mRNA export factor EB2 is essential for production of infectious virus.

Authors:  Henri Gruffat; Julien Batisse; Dagmar Pich; Bernhard Neuhierl; Evelyne Manet; Wolfgang Hammerschmidt; Alain Sergeant
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 9.  Anti-angiogenic gene therapy in the treatment of malignant gliomas.

Authors:  NaTosha N Gatson; E Antonio Chiocca; Balveen Kaur
Journal:  Neurosci Lett       Date:  2012-08-10       Impact factor: 3.046

10.  Plasmid DNA sequences present in conventional herpes simplex virus amplicon vectors cause rapid transgene silencing by forming inactive chromatin.

Authors:  Masataka Suzuki; Kazue Kasai; Yoshinaga Saeki
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.